Table 2:

Descriptive statistics of the percentage change in tumor size from baseline or nadir to follow-up examination (assigned per clinical protocol) for each response assessment classification per tumor measurement strategy

TRCMean (%)Standard Deviation (%)Minimum (%)Maximum (%)
CPcCPsaVol1Vol2CPcCPsaVol1Vol2CPcCPsaVol1Vol2CPcCPsaVol1Vol2
PD57837579647881592718942227224271271
SD61416813283220-27-68-735125918339
  • Note:—CPc indicates clinical cross-product; CPsa, semiautomated cross-product; Vol1, volume (25/50% tumor response criteria); Vol2, volume (40/65% tumor response criteria).